Senate Bill 3021
116th Congress(2019-2020)
Gluten in Medicine Disclosure Act of 2019
Introduced
Introduced in Senate on Dec 11, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
3021
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Gluten in Medicine Disclosure Act of 2019
This bill prohibits the sale of any drug intended for human use that contains an ingredient derived from a gluten-containing grain unless the drug's label (1)states that the drug contains such an ingredient, and (2)identifies the type of grain from which the ingredient is derived.
December 11, 2019
Sort by most recent
12/11/2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
12/11/2019
Introduced in Senate
Public Record
Record Updated
Oct 28, 2022 1:45:59 AM